Researchers at Stanford University have developed a new type of cancer therapy. The technology targets mucins, sugar-coated proteins that help cancer cells to metastasize and avoid the immune system. In particular, mucins enable cancer cells to survive free-floating as they travel through the blood during metastasis and can also trick immune cells into assuming that the cancer cell is not a threat. The new treatment involves combining an enzyme called mucinase with a cancer-specific nanobody that can bind to the cell surface, allowing the mucinase to destroy any mucins present.

Co-author:Pankaj Pandey (Senior Technical Architect / Director of Engineering, SCM Tech @ Tata 1mg)

Introduction

At Tata 1mg, our constant endeavor is to ensure seamless user access to our platforms, while simultaneously safeguarding user data against all forms of security threats and fraudulent activities.Organizations are currently grappling with the challenges posed by a variety of attacks that are directed toward disrupting their services or gaining unauthorized access to their systems.

Problem Statement

Building a Clearer Picture: Rethinking Log Messages and Log Pipeline for Superior Observability at 1mg

Co-Authors:

1. Pankaj Pandey (Senior Technical Architect / Director of Engineering, SCM Tech @ Tata 1mg)
2. Vimal Sharma (Technical Architect @ Tata 1mg)
3. Aman Garg (Associate Technical Architect @ Tata 1mg)

Introduction

LumaFlo, a medtech company based in Israel, has developed a decontamination technology that does not require UV light, something that can be dangerous for people nearby. The COVID-19 pandemic highlighted the need for safe and effective decontamination technologies for both public spaces and healthcare facilities. However, many such technologies rely on UV light to kill pathogens, but this can also have negative effects on those exposed.

Researchers at the Mount Sinai Hospital have developed an mRNA-based treatment for cancer. The approach combines the delivery of mRNA therapy in lipid nanoparticles and also involves co-delivering dendritic cells that have also been primed through treatment with lipid-encased mRNA. The technology aims to overcome some of the immune evasive tricks that tumors use to circumvent the immune system, some of which can hamper more traditional immunotherapies.

Researchers at MIT have developed a wearable ultrasound system that is intended to allow women at high risk of breast cancer to perform an ultrasound scan on themselves at home, and may also let patients with early-stage malignancy or suspicious lesions to monitor how they are progressing. The technology can help patients to avoid having to attend a clinic, and may also help them to identify tumors that arise between routine breast checks at a clinic.